Skip to main content
. 2014 Jun 17;111(4):689–695. doi: 10.1038/bjc.2014.327

Table 2. Clinico-pathological features in relation to pSrc-Y416.

Variables All cases, n (%) pSrcY416 (+), n (%) pSrcY416 (−), n (%) *P-value
Number
278 (100)
105 (37.8)
173 (62.2)
 
Age (years)
<50 88 (31.7) 34 (36.2) 54 (32)  
⩾50 175 (62.9) 60 (63.8) 115 (68) 0.487
Unknown
15 (5.4)
 
 
 
Size
5–20 mm 103 (37.1) 45 (48.9) 58 (36.3)  
>20 mm 149 (53.6) 47 (51.1) 102 (63.8) 0.049
Unknown
26 (9.4)
 
 
 
Grade
1 12 (4.3) 2 (1.9) 10 (5.8)  
2 93 (33.5) 33 (31.4) 61 (35.3)  
3
171 (61.5)
70 (66.7)
102 (59)
0.203
Necrosis
Absent 81 (29.1) 19 (35.8) 62 (52.5)  
Present 90 (32.4) 34 (64.2) 56 (47.5) 0.043
Unknown
107 (38.5)
 
 
 
LVI
Absent 203 (73) 70 (71.4) 133 (79.6)  
Present 62 (22.3) 28 (28.6) 34 (20.4) 0.127
Unknown
13 (4.7)
 
 
 
LN status
Negative 118 (42.4) 46 (46.9) 72 (43.4)  
Positive 146 (52.5) 52 (53.1) 94 (56.6) 0.573
Unknown
14 (5)
 
 
 
Stage
I 61 (21.9) 23 (22.8) 38 (22.6)  
II 109 (39.2) 39 (38.6) 70 (41.7)  
III 89 (32) 33 (32.7) 56 (33.3)  
IV 10 (3.6) 6 (5.9) 4 (2.4) 0.512
Unknown 9 (3.2)      

Abbreviations: LN=lymph nodes; LVI=lymph vascular invasion.

*All comparisons by Chi2 or Fisher tests.